HERO GRAFT
Report
- Report Number
- 3006945290-2014-00051
- Event Type
- Injury
- Date Received
- July 21, 2014
- Report Date
- June 19, 2014
- Manufacturer
- HEMOSPHERE, INC.
- Product Code
- DSY
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- PHYSICIAN
Narratives
THIS INVESTIGATION IS CURRENTLY ONGOING. ANY ADDITIONAL INFORMATION WILL BE PROVIDED IN THE FOLLOW-UP REPORT.
ACCORDING TO A MANUSCRIPT, THE END STAGE OF DIALYSIS ACCESS: FEMORAL GRAFT OR HERO VASCULAR ACCESS DEVICE, AN ARTERIAL GRAFT COMPONENT (AGC) BECAME INFECTED SIX WEEKS POST IMPLANT. WITHOUT INFORMATION ABOUT THE SOURCE OF THE INFECTION, TYPE OF INFECTION, PATIENT COMORBIDITIES, AND PRE-EXISTING INFECTIONS; THE RELATIONSHIP OF THE INFECTION TO THE HERO GRAFT DEVICE IN DR. (B)(6) PATIENT CANNOT BE DETERMINED. INFECTION IS A KNOWN POTENTIAL COMPLICATION LISTED IN THE HERO GRAFT INSTRUCTIONS FOR USE (IFU). THE HERO GRAFT IFU CONTRAINDICATES USE OF THE HERO DEVICE IN PATIENTS WITH KNOWN PREEXISTING BACTEREMIA. IN ADDITION, INSTRUCTIONS FOR SCREENING BLOOD CULTURES TO RULE OUT ASYMPTOMATIC BACTEREMIA AND RECOMMENDED ANTIBIOTIC THERAPY ARE ALSO PROVIDED IN THE IFU. THERE IS NO INDICATION THAT AN ERROR OR DEFICIENCY OCCURRED AT CRYOLIFE AND THE IFU ADEQUATELY COMMUNICATES RISK.
ACCORDING TO A MANUSCRIPT, THE END STAGE OF DIALYSIS ACCESS: FEMORAL GRAFT OR HERO VASCULAR ACCESS DEVICE, A PATIENT DEVELOPED A GRAFT INFECTION AFTER HERO GRAFT IMPLANT.
ACCORDING TO A MANUSCRIPT, THE END STAGE OF DIALYSIS ACCESS: FEMORAL GRAFT OR HERO VASCULAR ACCESS DEVICE, A PATIENT DEVELOPED A GRAFT INFECTION AFTER HERO GRAFT IMPLANT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 426027 | HERO GRAFT | VASCULAR GRAFT PROSTHESIS | DSY | HEMOSPHERE, INC. | HERO 1002 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |